Skip to main content
OpenTrials
Completed

NCT Number: NCT03697772

Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients

Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multimorbidity Continuity of Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Université Paris Cité

Paris, France

About this study

The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date.

This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study

Exclusion criteria

  • seen at home
  • unable to respond (cognitive problems or language barrier)

Treatment and study plan

Primary outcomes

  1. Continuity of care

    Time frame: over the past 1year

    Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)

  2. care pathway

    Time frame: over the past 1 year

    the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database

Secondary outcomes

  1. global quality of life

    Time frame: over the past 1 year

    EuroQol Health Questionnaire in 5 questions measuring quality of life by the EuroQol Group. (from 0 to 100, 100= good quality of life)

  2. burden of traitement

    Time frame: over the past 1 year

    Treatment Burden Questionnaire developped by VT Tran (from 0 to 130, 130 = treatments are a huge problem for the patient)

Sponsors and collaborators

Lead sponsor

University of Paris 5 - Rene Descartes

Other

Registry information

Acronym: MULTIPASS-2

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Oct 5, 2018
Registry last updated
May 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.